These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34331108)
1. Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells. Huot M; Caron M; Richer C; Djibo R; Najmanovich R; St-Onge P; Sinnett D; Raynal NJM Cancer Chemother Pharmacol; 2021 Nov; 88(5):845-856. PubMed ID: 34331108 [TBL] [Abstract][Full Text] [Related]
2. Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation. Da Costa EM; Armaos G; McInnes G; Beaudry A; Moquin-Beaudry G; Bertrand-Lehouillier V; Caron M; Richer C; St-Onge P; Johnson JR; Krogan N; Sai Y; Downey M; Rafei M; Boileau M; Eppert K; Flores-Díaz E; Haman A; Hoang T; Sinnett D; Beauséjour C; McGraw S; Raynal NJ J Exp Clin Cancer Res; 2019 Jun; 38(1):251. PubMed ID: 31196146 [TBL] [Abstract][Full Text] [Related]
3. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Marampon F; Bossi G; Ciccarelli C; Di Rocco A; Sacchi A; Pestell RG; Zani BM Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428 [TBL] [Abstract][Full Text] [Related]
4. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines. Kouraklis G; Triche TJ; Wesley R; Tsokos M Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Marampon F; Ciccarelli C; Zani BM Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113 [TBL] [Abstract][Full Text] [Related]
6. c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines. Gravina GL; Festuccia C; Popov VM; Di Rocco A; Colapietro A; Sanità P; Monache SD; Musio D; De Felice F; Di Cesare E; Tombolini V; Marampon F Radiat Res; 2016 Apr; 185(4):411-22. PubMed ID: 27104757 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124 [TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma. Vleeshouwer-Neumann T; Phelps M; Bammler TK; MacDonald JW; Jenkins I; Chen EY PLoS One; 2015; 10(12):e0144320. PubMed ID: 26636678 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells. Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758 [TBL] [Abstract][Full Text] [Related]
11. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases. Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660 [TBL] [Abstract][Full Text] [Related]
12. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells. Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023 [TBL] [Abstract][Full Text] [Related]
13. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation. Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816 [TBL] [Abstract][Full Text] [Related]
14. 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells. Marchesi I; Sanna L; Fais M; Fiorentino FP; Giordano A; Bagella L J Cell Physiol; 2018 Mar; 233(3):2360-2365. PubMed ID: 28722764 [TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. Steele N; Finn P; Brown R; Plumb JA Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094 [TBL] [Abstract][Full Text] [Related]
17. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target. Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505 [TBL] [Abstract][Full Text] [Related]
18. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts. Gozzini A; Santini V Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241 [TBL] [Abstract][Full Text] [Related]
19. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma. Slemmons KK; Crose LES; Riedel S; Sushnitha M; Belyea B; Linardic CM Mol Cancer Res; 2017 Dec; 15(12):1777-1791. PubMed ID: 28923841 [TBL] [Abstract][Full Text] [Related]
20. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]